MELEXIS NV (MELE.BR) Fundamental Analysis & Valuation

EBR:MELE • BE0165385973

Current stock price

66.35 EUR
+1.05 (+1.61%)
Last:

This MELE.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MELE.BR Profitability Analysis

1.1 Basic Checks

  • MELE had positive earnings in the past year.
  • In the past year MELE had a positive cash flow from operations.
  • MELE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.46%, MELE is in the better half of the industry, outperforming 67.69% of the companies in the same industry.
  • The Return On Equity of MELE (23.22%) is better than 67.69% of its industry peers.
  • The Return On Invested Capital of MELE (13.97%) is better than 66.15% of its industry peers.
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROIC 13.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • The Profit Margin of MELE (13.40%) is comparable to the rest of the industry.
  • MELE's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 15.96%, MELE is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MELE has remained more or less at the same level.
  • MELE has a worse Gross Margin (38.59%) than 75.38% of its industry peers.
  • MELE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

6

2. MELE.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MELE is still creating some value.
  • MELE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • MELE has an Altman-Z score of 6.66. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of MELE (6.66) is comparable to the rest of the industry.
  • MELE has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as MELE would need 3.32 years to pay back of all of its debts.
  • MELE's Debt to FCF ratio of 3.32 is in line compared to the rest of the industry. MELE outperforms 44.62% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that MELE is somewhat dependend on debt financing.
  • MELE has a worse Debt to Equity ratio (0.63) than 78.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Altman-Z 6.66
ROIC/WACC1.15
WACC12.14%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 5.46 indicates that MELE has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 5.46, MELE belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
  • MELE has a Quick Ratio of 2.63. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
  • MELE has a better Quick ratio (2.63) than 81.54% of its industry peers.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 2.63
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. MELE.BR Growth Analysis

3.1 Past

  • MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.04%.
  • Measured over the past years, MELE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.29% on average per year.
  • MELE shows a decrease in Revenue. In the last year, the revenue decreased by -9.99%.
  • Measured over the past years, MELE shows a quite strong growth in Revenue. The Revenue has been growing by 10.59% on average per year.
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.02% on average over the next years. This is quite good.
  • MELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.71% yearly.
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue Next Year0.9%
Revenue Next 2Y4.9%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

5

4. MELE.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.78 indicates a rather expensive valuation of MELE.
  • Based on the Price/Earnings ratio, MELE is valued cheaply inside the industry as 86.15% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of MELE to the average of the S&P500 Index (27.66), we can say MELE is valued inline with the index average.
  • A Price/Forward Earnings ratio of 22.02 indicates a rather expensive valuation of MELE.
  • MELE's Price/Forward Earnings ratio is rather cheap when compared to the industry. MELE is cheaper than 83.08% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.00, MELE is valued a bit cheaper.
Industry RankSector Rank
PE 23.78
Fwd PE 22.02
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MELE is valued a bit cheaper than 76.92% of the companies in the same industry.
  • MELE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MELE is cheaper than 89.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 27.65
EV/EBITDA 15.62
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MELE's earnings are expected to grow with 17.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.97
PEG (5Y)2.31
EPS Next 2Y17.16%
EPS Next 3Y17.33%

7

5. MELE.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.26%, MELE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.62, MELE pays a better dividend. On top of this MELE pays more dividend than 98.46% of the companies listed in the same industry.
  • MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 4.26%

5.2 History

  • On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years0
Div Non Decr Years7
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 131.42% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
  • MELE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP131.42%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELE.BR Fundamentals: All Metrics, Ratios and Statistics

MELEXIS NV

EBR:MELE (4/22/2026, 3:39:04 PM)

66.35

+1.05 (+1.61%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners17.67%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.68B
Revenue(TTM)839.62M
Net Income(TTM)112.51M
Analysts76
Price Target63.91 (-3.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.26%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP131.42%
Div Incr Years0
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.76%
Min EPS beat(2)-20.2%
Max EPS beat(2)-7.32%
EPS beat(4)1
Avg EPS beat(4)3.1%
Min EPS beat(4)-20.2%
Max EPS beat(4)42.38%
EPS beat(8)2
Avg EPS beat(8)-3.06%
EPS beat(12)5
Avg EPS beat(12)-2.06%
EPS beat(16)8
Avg EPS beat(16)0.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.88%
Revenue beat(12)2
Avg Revenue beat(12)-1.62%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)-0.61%
PT rev (3m)-11.47%
EPS NQ rev (1m)-8.07%
EPS NQ rev (3m)-11.05%
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-15.22%
Revenue NQ rev (1m)-2.5%
Revenue NQ rev (3m)-7.3%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-7.32%
Valuation
Industry RankSector Rank
PE 23.78
Fwd PE 22.02
P/S 3.19
P/FCF 27.65
P/OCF 21.22
P/B 5.53
P/tB 5.55
EV/EBITDA 15.62
EPS(TTM)2.79
EY4.2%
EPS(NY)3.01
Fwd EY4.54%
FCF(TTM)2.4
FCFY3.62%
OCF(TTM)3.13
OCFY4.71%
SpS20.78
BVpS11.99
TBVpS11.96
PEG (NY)2.97
PEG (5Y)2.31
Graham Number27.4386 (-58.65%)
Profitability
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROCE 16.8%
ROIC 13.97%
ROICexc 14.61%
ROICexgc 14.63%
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
FCFM 11.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Debt/EBITDA 1.64
Cap/Depr 55.05%
Cap/Sales 3.5%
Interest Coverage 14.46
Cash Conversion 67.44%
Profit Quality 86.17%
Current Ratio 5.46
Quick Ratio 2.63
Altman-Z 6.66
F-Score5
WACC12.14%
ROIC/WACC1.15
Cap/Depr(3y)125.38%
Cap/Depr(5y)110.34%
Cap/Sales(3y)6.34%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
EPS Next Y8%
EPS Next 2Y17.16%
EPS Next 3Y17.33%
EPS Next 5Y14.02%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%
Revenue Next Year0.9%
Revenue Next 2Y4.9%
Revenue Next 3Y6.08%
Revenue Next 5Y6.71%
EBIT growth 1Y-39.08%
EBIT growth 3Y-16.7%
EBIT growth 5Y12.03%
EBIT Next Year45.42%
EBIT Next 3Y25.78%
EBIT Next 5Y18.48%
FCF growth 1Y-22.5%
FCF growth 3Y-13.14%
FCF growth 5Y6.45%
OCF growth 1Y-29.12%
OCF growth 3Y-12.39%
OCF growth 5Y5.69%

MELEXIS NV / MELE.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MELE.BR.


What is the valuation status of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for MELEXIS NV?

MELEXIS NV (MELE.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of MELEXIS NV (MELE.BR) stock?

The Price/Earnings (PE) ratio for MELEXIS NV (MELE.BR) is 23.78 and the Price/Book (PB) ratio is 5.53.


Is the dividend of MELEXIS NV sustainable?

The dividend rating of MELEXIS NV (MELE.BR) is 7 / 10 and the dividend payout ratio is 131.42%.